$PCRX
Pacira BioSciences, Inc.

2014 Q1 Form 10-Q Financial Statement

#000139681414000006 Filed on May 01, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q1
Revenue $36.66M $11.59M
YoY Change 216.41% 48.48%
Cost Of Revenue $18.13M $11.39M
YoY Change 59.13% 75.38%
Gross Profit $18.54M $196.0K
YoY Change 9356.63% -85.03%
Gross Profit Margin 50.56% 1.69%
Selling, General & Admin $22.59M $12.94M
YoY Change 74.62% 16.0%
% of Gross Profit 121.87% 6600.0%
Research & Development $5.204M $5.905M
YoY Change -11.87% 356.34%
% of Gross Profit 28.08% 3012.76%
Depreciation & Amortization $2.603M $1.431M
YoY Change 81.9% 3.7%
% of Gross Profit 14.04% 730.1%
Operating Expenses $45.92M $30.23M
YoY Change 51.89% 59.61%
Operating Profit -$9.258M -$18.65M
YoY Change -50.35% 67.41%
Interest Expense $2.107M $1.519M
YoY Change 38.71% 195.53%
% of Operating Profit
Other Income/Expense, Net -$2.219M -$4.935M
YoY Change -55.04% 551.92%
Pretax Income -$11.48M -$23.58M
YoY Change -51.33% 98.15%
Income Tax $0.00 -$442.0K
% Of Pretax Income
Net Earnings -$11.48M -$23.14M
YoY Change -50.4% 94.54%
Net Earnings / Revenue -31.3% -199.69%
Basic Earnings Per Share -$0.34 -$0.71
Diluted Earnings Per Share -$0.34 -$0.71
COMMON SHARES
Basic Shares Outstanding 33.71M shares 32.71M shares
Diluted Shares Outstanding 33.71M shares 32.71M shares

Balance Sheet

Concept 2014 Q1 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.60M $110.2M
YoY Change -41.38% 101.09%
Cash & Equivalents $18.76M $26.27M
Short-Term Investments $45.80M $84.00M
Other Short-Term Assets $2.600M $2.700M
YoY Change -3.7% 80.0%
Inventory $15.36M $10.76M
Prepaid Expenses
Receivables $15.97M $5.243M
Other Receivables $0.00 $0.00
Total Short-Term Assets $98.48M $129.0M
YoY Change -23.65% 107.16%
LONG-TERM ASSETS
Property, Plant & Equipment $49.89M $41.13M
YoY Change 21.3% 55.25%
Goodwill $11.33M $8.582M
YoY Change 31.99%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.353M $3.845M
YoY Change -12.8% 404.59%
Total Long-Term Assets $65.22M $56.25M
YoY Change 15.93% 75.79%
TOTAL ASSETS
Total Short-Term Assets $98.48M $129.0M
Total Long-Term Assets $65.22M $56.25M
Total Assets $163.7M $185.2M
YoY Change -11.63% 96.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.605M $1.001M
YoY Change 160.24% -56.52%
Accrued Expenses $16.91M $9.872M
YoY Change 71.32% 40.23%
Deferred Revenue
YoY Change
Short-Term Debt $100.0M $0.00
YoY Change
Long-Term Debt Due $1.100M $900.0K
YoY Change 22.22% -34.02%
Total Short-Term Liabilities $121.6M $12.70M
YoY Change 857.53% -33.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $95.86M
YoY Change -100.0% 305.62%
Other Long-Term Liabilities $3.435M $2.694M
YoY Change 27.51% 0.71%
Total Long-Term Liabilities $3.435M $98.55M
YoY Change -96.51% 274.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $121.6M $12.70M
Total Long-Term Liabilities $3.435M $98.55M
Total Liabilities $128.0M $115.4M
YoY Change 10.86% 102.46%
SHAREHOLDERS EQUITY
Retained Earnings -$307.9M -$255.7M
YoY Change 20.44% 33.06%
Common Stock $34.00K $33.00K
YoY Change 3.03% 32.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.000K
YoY Change 0.0%
Treasury Stock Shares 0.000 shares 1.065K shares
Shareholders Equity $35.71M $69.79M
YoY Change
Total Liabilities & Shareholders Equity $163.7M $185.2M
YoY Change -11.63% 96.51%

Cashflow Statement

Concept 2014 Q1 2013 Q1
OPERATING ACTIVITIES
Net Income -$11.48M -$23.14M
YoY Change -50.4% 94.54%
Depreciation, Depletion And Amortization $2.603M $1.431M
YoY Change 81.9% 3.7%
Cash From Operating Activities -$4.740M -$13.79M
YoY Change -65.63% -21.42%
INVESTING ACTIVITIES
Capital Expenditures $3.808M $2.932M
YoY Change 29.88% 1.07%
Acquisitions
YoY Change
Other Investing Activities $12.83M -$53.32M
YoY Change -124.06% -14510.81%
Cash From Investing Activities $9.020M -$56.25M
YoY Change -116.04% 2123.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.964M 86.19M
YoY Change -97.72% -9894.32%
NET CHANGE
Cash From Operating Activities -4.740M -13.79M
Cash From Investing Activities 9.020M -56.25M
Cash From Financing Activities $1.964M 86.19M
Net Change In Cash $1.964M 16.15M
YoY Change -87.84% -177.05%
FREE CASH FLOW
Cash From Operating Activities -$4.740M -$13.79M
Capital Expenditures $3.808M $2.932M
Free Cash Flow -$8.548M -$16.72M
YoY Change -48.88% -18.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3069000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2605000 USD
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15969000 USD
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14590000 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16913000 USD
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17885000 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14586000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12576000 USD
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5000 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5000 USD
CY2014Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
343578000 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
337639000 USD
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3975000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2225000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3975000 USD
CY2014Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1035000 USD
CY2013Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
855000 USD
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 USD
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5100000 shares
CY2014Q1 us-gaap Assets
Assets
163693000 USD
CY2013Q4 us-gaap Assets
Assets
169820000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
98478000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
106751000 USD
CY2014Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45806000 USD
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
59632000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18762000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12515000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26272000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10126000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33802182 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33636442 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33802182 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33636442 shares
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
34000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
34000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23121000 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11477000 USD
CY2013Q4 us-gaap Convertible Debt
ConvertibleDebt
120000000 USD
CY2014Q1 us-gaap Convertible Debt
ConvertibleDebt
120000000 USD
CY2014Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
99996000 USD
CY2013Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
98961000 USD
CY2013Q1 us-gaap Cost Of Revenue
CostOfRevenue
11391000 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
18127000 USD
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
21039000 USD
CY2014Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20004000 USD
CY2014Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1008000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1008000 USD
CY2014Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2960000 USD
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3212000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
900000 USD
CY2014Q1 us-gaap Depreciation
Depreciation
2100000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1431000 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2603000 USD
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13843000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14356000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15000000 USD
CY2014Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
644000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1157000 USD
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3398000 USD
CY2014Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2013Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
CY2014Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3398000 USD
CY2014Q1 us-gaap Goodwill
Goodwill
11327000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
10328000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
8000000 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11477000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23580000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-442000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1531000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
162000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1379000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
891000 USD
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-252000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-243000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1317000 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-193000 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
278000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
450000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
868000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-237000 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1633000 USD
CY2013Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1523000 USD
CY2014Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000 USD
CY2013Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
1519000 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
2107000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
584000 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
2251000 USD
CY2014Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3408000 USD
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3946000 USD
CY2014Q1 us-gaap Inventory Net
InventoryNet
15364000 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
15557000 USD
CY2014Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4199000 USD
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5290000 USD
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6321000 USD
CY2014Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7757000 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
42000 USD
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
73000 USD
CY2014Q1 us-gaap Liabilities
Liabilities
127982000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
128571000 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
163693000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169820000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
121943000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
121587000 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
98961000 USD
CY2014Q1 us-gaap Long Term Debt
LongTermDebt
99996000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
16146000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
6247000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
86186000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1964000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-56251000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
9019000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-13789000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4736000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-11477000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-23138000 USD
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4935000 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2219000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
45920000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
30232000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18645000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9258000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
41663000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
5725000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
5578000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
5436000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5297000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
15899000 USD
CY2014Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
3728000 USD
CY2014Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3353000 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3402000 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000 USD
CY2014Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
17000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3435000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3190000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34000 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7191000 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2932000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3808000 USD
CY2014Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18946000 USD
CY2013Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
71785000 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2572000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2819000 USD
CY2013Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
120000000 USD
CY2014Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2013Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
18750000 USD
CY2014Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
32772000 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1964000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
877000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60758000 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64477000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49891000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48182000 USD
CY2013Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
27500000 USD
CY2014Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5204000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5905000 USD
CY2014Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 USD
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1633000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307906000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296429000 USD
CY2014Q1 us-gaap Revenues
Revenues
36662000 USD
CY2013Q1 us-gaap Revenues
Revenues
11587000 USD
CY2014Q1 us-gaap Royalty Expense
RoyaltyExpense
120000 USD
CY2013Q1 us-gaap Royalty Expense
RoyaltyExpense
86000 USD
CY2014Q1 us-gaap Royalty Revenue
RoyaltyRevenue
668000 USD
CY2013Q1 us-gaap Royalty Revenue
RoyaltyRevenue
509000 USD
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
35742000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10835000 USD
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22589000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12936000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3975000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2225000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
5204537 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
14437 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
5190100 shares
CY2014Q1 us-gaap Share Price
SharePrice
69.99
CY2014Q1 us-gaap Short Term Investments
ShortTermInvestments
45811000 USD
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
59637000 USD
CY2014Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1964000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
41249000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
35711000 USD
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32709298 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33710970 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33711000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32709000 shares
CY2013Q1 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
94000 USD
CY2014Q1 pcrx Amortization Of Other Assets And Unfavorable Lease Obligation
AmortizationOfOtherAssetsAndUnfavorableLeaseObligation
122000 USD
CY2014Q1 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
13000 USD
CY2014Q1 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
8000 USD
CY2013Q4 pcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
8000 USD
CY2013Q1 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
243000 USD
CY2014Q1 pcrx Collaborative Licensing And Development Revenue
CollaborativeLicensingAndDevelopmentRevenue
252000 USD
CY2012Q2 pcrx Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition
ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition
2000000 USD
CY2014Q1 pcrx Debt Instrument Convertible Conversion Premium Shares
DebtInstrumentConvertibleConversionPremiumShares
3100000.0 shares
CY2014Q1 pcrx Debt Instrument Convertible Conversion Value
DebtInstrumentConvertibleConversionValue
218000000 USD
CY2013Q1 pcrx Equity Premium Convertible Debt
EquityPremiumConvertibleDebt
24936000 USD
CY2014Q1 pcrx Equity Premium Convertible Debt
EquityPremiumConvertibleDebt
0 USD
CY2014Q1 pcrx Goodwill Recordedfor Earn Out Payments
GoodwillRecordedforEarnOutPayments
999000 USD
CY2013Q1 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
104000 USD
CY2014Q1 pcrx Increase Decrease In Royalty Interest Obligation
IncreaseDecreaseInRoyaltyInterestObligation
181000 USD
CY2013Q4 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
100207000 USD
CY2014Q1 pcrx Long Term Debt Including Royalty Interest Obligation
LongTermDebtIncludingRoyaltyInterestObligation
101061000 USD
CY2013 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2014Q1 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 customer
CY2012Q2 pcrx Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition
PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition
10000000 USD
CY2014Q1 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
999000 USD
CY2013Q1 pcrx Payment Of Contingent Consideration
PaymentOfContingentConsideration
284000 USD
CY2014Q1 pcrx Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
6995000 shares
CY2013Q1 pcrx Proceeds From Sale Of Unused Net Operating Losses
ProceedsFromSaleOfUnusedNetOperatingLosses
400000 USD
CY2013Q4 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
1246000 USD
CY2014Q1 pcrx Royalty Interest Obligation
RoyaltyInterestObligation
1065000 USD
CY2013Q4 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1020000 USD
CY2014Q1 pcrx Royalty Interest Obligation Current
RoyaltyInterestObligationCurrent
1065000 USD
CY2013Q4 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
226000 USD
CY2014Q1 pcrx Royalty Interest Obligation Noncurrent
RoyaltyInterestObligationNoncurrent
0 USD
CY2014Q1 pcrx Total Goodwill Recordedfor Earn Out Payments
TotalGoodwillRecordedforEarnOutPayments
3300000 USD
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001396814
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35655095 shares
CY2014Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
Pacira Pharmaceuticals, Inc.

Files In Submission

Name View Source Status
0001396814-14-000006-index-headers.html Edgar Link pending
0001396814-14-000006-index.html Edgar Link pending
0001396814-14-000006.txt Edgar Link pending
0001396814-14-000006-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
pcrx-20140331.xml Edgar Link completed
pcrx-20140331.xsd Edgar Link pending
pcrx-20140331_cal.xml Edgar Link unprocessable
pcrx-20140331_def.xml Edgar Link unprocessable
pcrx-20140331_lab.xml Edgar Link unprocessable
pcrx-20140331_pre.xml Edgar Link unprocessable
pcrx-33114xex101.htm Edgar Link pending
pcrx-33114xex311.htm Edgar Link pending
pcrx-33114xex312.htm Edgar Link pending
pcrx-33114xex321.htm Edgar Link pending
pcrx-33114xex322.htm Edgar Link pending
pcrx-3312014x10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending